Pingtian Ding
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Molecular Medicine top 5%
Papers in
-
- RNA Interference and Gene Delivery 24
- Advanced biosensing and bioanalysis techniques 12
- Extracellular vesicles in disease 7
-
- Advanced Drug Delivery Systems 9
- Advancements in Transdermal Drug Delivery 7
- Co-authors
- Tianzhi Yang (29 shared papers)Haonan Xing (15 shared papers)Weisan Pan (4 shared papers)Mei Lu (10 shared papers)Xiaoyun Zhao (21 shared papers)Dongkai Wang (6 shared papers)Cuifang Cai (11 shared papers)Zhe Xun (6 shared papers)
- Journals
- Asian Journal of Pharmaceutical Sciences (6 papers)International Journal of Pharmaceutics (5 papers)Biomedical Chromatography (4 papers)Acta Biomaterialia (4 papers)Acta Pharmaceutica Sinica B (3 papers)
- Partner nations
- ChinaUnited StatesMexico
In The Last Decade
Pingtian Ding
60 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 112
- Pharmaceutical Science 439
- Molecular Medicine 103
- Biomaterials 282
- Cancer Research 171
- Automotive Engineering 136
Countries citing papers authored by Pingtian Ding
This map shows the geographic impact of Pingtian Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingtian Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingtian Ding more than expected).
Fields of papers citing papers by Pingtian Ding
This network shows the impact of papers produced by Pingtian Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingtian Ding. The network helps show where Pingtian Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingtian Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 237 | |
| 2 | 2018 | 130 | |
| 3 | 2016 | 94 | |
| 4 | 2021 | 93 | |
| 5 | 2017 | 84 | |
| 6 | 2019 | 63 | |
| 7 | 2018 | 57 | |
| 8 | 2018 | 56 | |
| 9 | 2013 | 55 | |
| 10 | 2018 | 50 | |
| 11 | 2022 | 48 | |
| 12 | 2018 | 47 | |
| 13 | 2006 | 42 | |
| 14 | 2016 | 35 | |
| 15 | 2016 | 33 | |
| 16 | 2018 | 32 | |
| 17 | 2018 | 27 | |
| 18 | 2006 | 26 | |
| 19 | 2016 | 25 | |
| 20 | Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. | 2005 | 24 |
About Pingtian Ding
Pingtian Ding is a scholar working on Molecular Biology, Pharmaceutical Science, Genetics, Biomedical Engineering and Biomaterials, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (24 papers), Virus-based gene therapy research (13 papers), Advanced biosensing and bioanalysis techniques (12 papers), Advanced Drug Delivery Systems (9 papers), Advancements in Transdermal Drug Delivery (7 papers), Extracellular vesicles in disease (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pharmaceutical Science (439 citations), Molecular Medicine (103 citations), Biomaterials (282 citations), Cancer Research (171 citations) and Automotive Engineering (136 citations). Pingtian Ding has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Tianzhi Yang, Haonan Xing, Weisan Pan, Mei Lu, Xiaoyun Zhao, Dongkai Wang, Cuifang Cai, Zhe Xun, Jiawei Li and Zhidong Liu. Their work appears in journals such as Asian Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics, Biomedical Chromatography, Acta Biomaterialia and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.